本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vir Biotechnology, Inc.

11.08
+0.37003.45%
盘后11.07-0.0100-0.09%19:55 EDT
成交量:224.86万
成交额:2,416.64万
市值:18.69亿
市盈率:-6.53
高:11.12
开:10.60
低:10.30
收:10.71
52周最高:11.66
52周最低:4.36
股本:1.69亿
流通股本:1.30亿
量比:1.17
换手率:1.73%
股息:- -
股息率:- -
每股收益(TTM):-1.6972
每股收益(LYR):-3.1619
净资产收益率:-26.08%
总资产收益率:-14.51%
市净率:1.90
市盈率(LYR):-3.50

数据加载中...

2026/08/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/24

重要事件披露

Form 8-K - Current report
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/10

重要事件披露

Form 8-K - Current report
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities